Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia-Reference-Cited by-同舟云学术

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia

Published:2022-08-22 Issue:8 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Taylor-Rowan Martin¹,Kraia Olga¹,Kolliopoulou Christina¹,Noel-Storr Anna H²,Alharthi Ahmed A.³,Cross Amanda J⁴,Stewart Carrie⁵,Myint Phyo K⁶,McCleery Jenny⁷,Quinn Terry J¹

Affiliation:

1. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

2. Radcliffe Department of Medicine; University of Oxford; Oxford UK

3. Department of Clinical Pharmacy; Umm Al Qura University; Makkah Saudi Arabia

4. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences; Monash University; Parkville Australia

5. ACER; IAHS, University of Aberdeen; Aberdeen UK

6. Division of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition; University of Aberdeen; Aberdeen UK

7. Oxford Health NHS Foundation Trust; Banbury UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference88 articles.

1. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: a population-based study;Ah;Basic & Clinical Pharmacology & Toxicology,2019

2. The anticholinergic effect on cognition (AEC) scale-Associations with mortality, hospitalisation and cognitive decline following dementia diagnosis;Bishara;International Journal of Geriatric Psychiatry,2020

3. Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease;Bottiggi;American Journal of Geriatric Psychiatry,2007

4. Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes;Boudreau;The American Journal of Geriatric Psychiatry,2011

5. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics;Cross;J Alzheimers Dis,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug burden index of people ageing with intellectual disability and cognitive complaints attending a specialist memory service;Journal of Intellectual Disability Research;2024-08-26

2. Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment;Cochrane Database of Systematic Reviews;2023-12-08

3. New horizons in evidence synthesis for older adults;Age and Ageing;2023-11-02

4. Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia;Schizophrenia Research;2023-10

5. Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies;Current Neurology and Neuroscience Reports;2023-07-31